AKKARAJU SRINIVAS

CIK 00012531706 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001253170

Recent Transactions

50 trades

Purchase
ALUMIS INC.$ALMS
Common Stock
2025-12-04$8.18/sh+66,027→ 1,078,876 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-12-04$8.18/sh+66,027→ 1,078,876 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-12-03$7.75/sh+100,000→ 1,012,849 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-12-03$7.75/sh+100,000→ 1,012,849 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-12-02$7.55/sh+96,000→ 912,849 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-12-02$7.55/sh+96,000→ 912,849 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-12-01$7.46/sh+86,350→ 816,849 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-12-01$7.46/sh+86,350→ 816,849 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-11-28$7.64/sh+38,702→ 730,499 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-11-28$7.64/sh+38,702→ 730,499 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-11-26$7.64/sh+48,537→ 691,797 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-11-26$7.64/sh+48,537→ 691,797 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Restricted Stock Units
2013-07-16−325→ 1,622 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common stock
2013-07-16+325→ 2,304 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Restricted Stock Units
2013-07-16−325→ 1,622 total
Exercise/Conversion
INTERCEPT PHARMACEUTICALS, INC.
Common stock
2013-07-16+325→ 2,304 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2013-05-17$36.70/sh+8,750→ 8,750 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2013-05-17$36.70/sh+8,750→ 8,750 total
Award
Seagen Inc.
Common Stock
2013-05-17+3,500→ 13,905 total
Award
Seagen Inc.
Common Stock
2013-05-17+3,500→ 13,905 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−297→ 29,301 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−297→ 29,301 total
Award
Seagen Inc.
Stock Options (Right to Purchase)
2008-05-16+10,000→ 10,000 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−716→ 70,636 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−2,664→ 262,998 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−5,250→ 518,153 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−1,973→ 194,720 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−31,159→ 811,175 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−2,664→ 262,998 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−1,973→ 194,720 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−31,159→ 811,175 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−716→ 70,636 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-16$10.39/sh−5,250→ 518,153 total
Award
Seagen Inc.
Stock Options (Right to Purchase)
2008-05-16+10,000→ 10,000 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−6,257→ 265,662 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−73,162→ 842,334 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−4,633→ 196,693 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−73,162→ 842,334 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−6,257→ 265,662 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−12,328→ 523,403 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−697→ 29,598 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−12,328→ 523,403 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−697→ 29,598 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−1,681→ 71,352 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−4,633→ 196,693 total
Sale
Seagen Inc.
Class A Common Stock
2008-05-15$10.14/sh−1,681→ 71,352 total
Award
EYETECH PHARMACEUTICALS INC
Common Stock
2005-06-28$0.01/sh+17,500→ 2,275,896 total
Award
EYETECH PHARMACEUTICALS INC
Common Stock
2005-06-28$0.01/sh+17,500→ 2,275,896 total
Purchase
Seagen Inc.
Series A Convertible Preferred Stock
2004-12-30$22.80/sh+30,491→ 304,910 total
Purchase
Seagen Inc.
Series A Convertible Preferred Stock
2004-12-30$22.80/sh+30,491→ 304,910 total

Companies

Recent Filings

Address

C/O JPMORGAN PARTNERS 1221 AVE OF THE AMERICAS 40TH FLOOR

NEW YORK, NY, 10020

View on SEC.gov